The new “Hot Topics” webinar series will give you a peek behind the curtain and help answer the tough questions about the evaluation and reimbursement of new cancer medicines.
In this four-part webinar series, we will explore:
pCPA and provincial listings
Wednesday Nov 23, 2022 @1pm Eastern
Hear from Health Policy Expert Judith Glennie and Colorectal Cancer Canada President Barry Stein about why timelines for public reimbursement of cancer medicines are getting longer and how this impacts patients.
Tuesday Dec 13, 2022 @1pm Eastern
Join Dr. Howard Lim (Oncologist), Alexandra Chambers (Novartis) and Bob Bick (CanCertainty) to learn about decisions on what cancer medicines patients can access across different lines of treatments.
Tuesday Jan 24, 2023 @1pm Eastern
How arbitrary decisions on cost-effectiveness impact patients’ access to some novel cancer treatments.
Tuesday Feb 21, 2023 @1pm Eastern
Are drug review processes flexible enough to expedite patients’ access to new cancer medicines?